Viewing Study NCT00794235


Ignite Creation Date: 2025-12-24 @ 10:41 PM
Ignite Modification Date: 2026-05-27 @ 9:00 AM
Study NCT ID: NCT00794235
Status: COMPLETED
Last Update Posted: 2010-01-08
First Post: 2008-11-19
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Monocentric Pilot Study Investigating the Metabolic Activity of Melanoma in Vivo During Sorafenib and Dacarbazine
Sponsor: University of Zurich
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Melanoma Stage III or IV View
None No Prior Chemotherapy View
Keywords: